Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Windpessl

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Wiener Klinische Wochenschrift|August 31, 2022
Chronic kidney disease is more prevalent among women but more men than women are under nephrological care : Analysis from six outpatient clinics in Austria 2019Michal J Lewandowski, Simon Krenn, Amelie Kurnikowski, et al.
American Journal of Nephrology|August 27, 2024
Patient and Caregiver Perspectives on Gender Disparity in Chronic Kidney Disease: Questionnaire Survey, Based on an Interview StudyLenka Vanek, Dilara Gülmez, Amelie Kurnikowski, et al.
Kidney360|October 25, 2024
Patient and Caregiver Perspectives on Gender Disparity in CKD: An Interview StudyMichał J Lewandowski, Amelie Kurnikowski, Lenka Vanek, et al.
Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Journal of the American Society of Nephrology : JASN|October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Orphanet Journal of Rare Diseases|November 10, 2019
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathyNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Clinical Kidney Journal|April 17, 2020
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysisNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Frontiers in Immunology|September 27, 2021
FHR-5 Serum Levels and <i>CFHR5</i> Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-GlomerulopathyNóra Garam, Marcell Cserhalmi, Zoltán Prohászka, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Wiener Klinische Wochenschrift|August 31, 2022
Chronic kidney disease is more prevalent among women but more men than women are under nephrological care : Analysis from six outpatient clinics in Austria 2019Michal J Lewandowski, Simon Krenn, Amelie Kurnikowski, et al.
American Journal of Nephrology|August 27, 2024
Patient and Caregiver Perspectives on Gender Disparity in Chronic Kidney Disease: Questionnaire Survey, Based on an Interview StudyLenka Vanek, Dilara Gülmez, Amelie Kurnikowski, et al.
Kidney360|October 25, 2024
Patient and Caregiver Perspectives on Gender Disparity in CKD: An Interview StudyMichał J Lewandowski, Amelie Kurnikowski, Lenka Vanek, et al.
Frontiers in Immunology|September 28, 2023
COVID-19 outcomes in patients with a history of immune-mediated glomerular diseasesPhilipp Gauckler, Jana S Kesenheimer, Duvuru Geetha, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Kidney International Reports|April 29, 2021
Rituximab in Membranous NephropathyPhilipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Journal of the American Society of Nephrology : JASN|October 21, 2024
Long-Term Outcomes of Rituximab-Treated Adult Patients with PodocytopathiesPhilipp Gauckler, Anna Matyjek, Seleni Kapsia, et al.
Orphanet Journal of Rare Diseases|November 10, 2019
C4 nephritic factor in patients with immune-complex-mediated membranoproliferative glomerulonephritis and C3-glomerulopathyNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Clinical Kidney Journal|April 17, 2020
Validation of distinct pathogenic patterns in a cohort of membranoproliferative glomerulonephritis patients by cluster analysisNóra Garam, Zoltán Prohászka, Ágnes Szilágyi, et al.
Frontiers in Immunology|September 27, 2021
FHR-5 Serum Levels and <i>CFHR5</i> Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-GlomerulopathyNóra Garam, Marcell Cserhalmi, Zoltán Prohászka, et al.
Pageof 7